Ben Rapinoja

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Gold - Individuals: litigation

“Borenius Attorneys is at the very top of the patent litigation leader board, and rightfully so”, comments one interviewee. The firm is a repository of trust for many A-list generic pharmaceutical companies and industry heavyweights generally, and regularly appears in many of the country’s precedent-setting cases. For instance, it recently appeared on behalf of TEVA in a pan-European supplementary protection certificate (SPC) dispute against Merck Sharp Dohme, the outcome of which has the potential to bring clarity to a longstanding debate over the interpretation of Article 3 of the SPC Regulation. Another highlight includes its work on behalf of Mylan, which saw Ben Rapinoja battle it out against Gilead Sciences. In the words of one peer: “Ben is one of Finland’s major litigators and has an immensely successful practice. He gives excellent advice and his profound expertise and knowledge is evident in his work – many who have appeared against him in a dispute have walked away in defeat.” Further contentious firepower is brought by Lasse Laaksonen, “a true professional, excellent negotiator and an even better litigator”. He has been kept busy recently by the likes of Onninen, a leading wholesale provider of technical goods, and Giovanni Ogna e Figli, as well as its holding company Primex, a pharmaceutical group in Switzerland. Technology and data practice co-head Samuli Simojoki shines when brokering IP-rich deals. Lately, he has been working with Helsinki University Central Hospital on the planning, structuring and commercialisation of some of their R&D projects.

Get unlimited access to all IAM content